Detalhe da pesquisa
1.
Immune Responses to the ChAdOx1 nCoV-19 and BNT162b2 Vaccines and to Natural Coronavirus Disease 2019 Infections Over a 3-Month Period.
J Infect Dis
; 225(5): 777-784, 2022 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34850034
2.
Comparison of Waning Neutralizing Antibody Responses Against the Omicron Variant 6 Months After Natural Severe Acute Respiratory Syndrome Coronavirus 2 Infection (With or Without Subsequent Coronavirus Disease 2019 [COVID-19] Vaccination) Versus 2-Dose COVID-19 Vaccination.
Clin Infect Dis
; 75(12): 2243-2246, 2022 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35686300
3.
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs.
Antimicrob Agents Chemother
; 64(7)2020 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32366720
4.
Efficient long-term amplification of hepatitis B virus isolates after infection of slow proliferating HepG2-NTCP cells.
J Hepatol
; 71(2): 289-300, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31077792
5.
High-throughput screening of small-molecules libraries identified antibacterials against clinically relevant multidrug-resistant A. baumannii and K. pneumoniae.
EBioMedicine
; 102: 105073, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38520916
6.
Immunogenicity and Durability of Antibody Responses to Homologous and Heterologous Vaccinations with BNT162b2 and ChAdOx1 Vaccines for COVID-19.
Vaccines (Basel)
; 10(11)2022 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36366372
7.
Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19.
Microorganisms
; 10(8)2022 Aug 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36014057
8.
A new high-content screening assay of the entire hepatitis B virus life cycle identifies novel antivirals.
JHEP Rep
; 3(4): 100296, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34222850
9.
Correlation between Reactogenicity and Immunogenicity after the ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccination.
Immune Netw
; 21(6): e41, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35036028
10.
Comparison of Antibody and T Cell Responses Induced by Single Doses of ChAdOx1 nCoV-19 and BNT162b2 Vaccines.
Immune Netw
; 21(4): e29, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34522442
11.
Identification and characterization of a novel hepatitis B virus pregenomic RNA encapsidation inhibitor.
Antiviral Res
; 175: 104709, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31940474
12.
No correlation of neutralizing antibody titers against the Omicron variant after a booster dose of COVID-19 vaccines with subsequent breakthrough Omicron infections among healthcare workers.
J Infect
; 85(6): e177-e180, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36223860
13.
Breakthrough infections and waning immune responses with ChAdOx1 nCoV-19 or mRNA vaccine in healthcare workers.
Clin Transl Med
; 12(4): e804, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35452187